Stock search

Ticker or company name

Cigna

CI · NYSE · Health Care

$300,16Up +3,16 (+1,06%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$78,3 bn
Div. yield
1,7%
Year to date
+7,9%
52 weeks: $257,85$318,05

Ratio score

89/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

7 ✓ · 2 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM13,114,625,1
Forward P/E9,1—16,2
PEG1,4—2,2
P/S0,30,42,2
EV/EBITDA8,910,417,3
P/FCF8,7—19,5
P/B1,81,83,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 34 analysts

Buy
25
Hold
9
Sell
0

Beat the EPS forecast in 1 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20267,737,98Up +3,3%
Q2 20267,837,78Down −0,6%
Q1 20267,847,79Down −0,7%
Q4 20258,118,08Down −0,4%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue73,7 bn71,7 bn68,5 bn72,5 bn69,7 bn67,2 bn65,5 bn65,6 bn63,7 bn60,5 bn57,3 bn51,1 bn
EPS5,476,296,264,666,985,714,855,072,635,45−0,973,50
Margin2,3%2,6%2,7%1,8%2,8%2,4%2,2%2,3%1,3%2,7%−0,4%2,2%
FCF2,57 bn−421 m1,13 bn6,15 bn3,42 bn−1,89 bn1,92 bn5,21 bn46,0 m265 m4,84 bn1,47 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $66,8 m.

NameAmountSharesPrice
neville everett3 Sep 2026 · sale$175 259617$284,05
jones nicole s18 Aug 2026 · sale$748 5162 677$279,61
jones nicole s4 Aug 2026 · sale$5,37 m19 436$276,27
kates jamie g12 Jun 2026 · sale$268 452899$298,61
cordani david12 May 2026 · sale$666 0272 231$298,53
cordani david12 May 2026 · sale$4,57 m15 319$298,24
cordani david12 May 2026 · sale$598 7182 017$296,84
cordani david12 May 2026 · sale$10,3 m34 641$295,98
cordani david12 May 2026 · sale$11,4 m38 487$294,98
cordani david12 May 2026 · sale$629 5742 142$293,92
cordani david12 May 2026 · sale$2,30 m7 861$292,88
cordani david12 May 2026 · sale$3,60 m12 315$291,95
cordani david12 May 2026 · sale$4,00 m13 732$291,01
cordani david12 May 2026 · sale$11,9 m41 099$290,00
cordani david12 May 2026 · sale$4,00 m13 839$288,85

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
1 Apr 1982

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
CORCencora$356,9483would consider19,7+5,1%0,8%
ELVElevance Health$446,2878would consider18,1+3,6%2,5%
CAHCardinal Health$283,85no score35,7——
BSXBoston Scientific$43,6983would consider18,4+8,9%16,6%
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.